Great job, Joe. I already had that conversation on a Gnbt conference call years ago with Dr von Hofe where we discussed the disappointment of the overall results and I talked about excitement in the results for trip neg. And my point remains that no matter how you dice it that’s not the same market as discussed in the prior appraisal.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links